GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate

Source :: GlobeNewswire. April 6, 2023
Publication Year :: 2023
Abstract: Analysis of Open-Label Portion of Ongoing Phase 2 Trial of GEO-CM04S1 Presented at 23rd Annual World Vaccine Congress Atlanta, GA, April 06, 2023 (GLOBE NEWSWIRE) -- via https://www.globenewswire.com/Tracker?data=MLSZ63jwqRcUw0jzQaTWyr8B6GlGr9QdSnc4aFNkicEXnVU22AJEfsfCjAM0BPBqTIH-l2AvP7Oev1Np7qHk4LpuoCbYyZBelgdxgbw_EHU= GeoVax Labs, [...]

Subjects :: T cells -- Health aspects
Antigens -- Health aspects
Hematopoietic stem cells -- Transplantation
Clinical trials -- Health aspects
Vaccines -- Health aspects
Banking, finance and accounting industries
Business

Tools